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O B J E C T I V E S This study investigated the effects of age, duration of a high-fat diet, and type 2
diabetes on atherosclerotic plaque development and uptake of 18F-ﬂuorodeoxyglucose (18F-FDG) in 2
mouse models.
B A C KG ROUND The animal’s age and start time and duration of a high-fat diet have effects on
plaque composition in atherosclerotic mice.
METHOD S The aortas of atherosclerotic low-density lipoprotein receptor deﬁcient mice expressing
only apolipoprotein B100 (LDLR/ApoB100/100) and atherosclerotic and diabetic mice overexpressing
insulin-like growth factor II (IGF-II/LDLR/ApoB100/100) were investigated at 4, 6, and 12 months of age
and older after varying durations of high-fat diet. C57BL/6N mice on normal chow served as controls.
Plaque size (intima-to-media ratio), macrophage density (Mac-3 staining), and plaque uptake of 18F-FDG
were studied by means of in vivo positron emission tomography/computed tomography by ex vivo
autoradiography and by histological and immunohistochemical methods.
R E S U L T S From the ages of 4 to 6 months and 12 months and older, the plaque size increased and
the macrophage density decreased. Compared with the controls, the in vivo imaging showed increased
aortic 18F-FDG uptake at 4 and 6 months, but not at 12 months and older. Autoradiography showed focal
18F-FDG uptake in plaques at all time points (average plaque-to-normal vessel wall ratio: 2.4  0.4, p 
0.001) with the highest uptake in plaques with high macrophage density. There were no differences in
the plaque size, macrophage density, or uptake of 18F-FDG between LDLR/ApoB100/100 and
IGF-II/LDLR/ApoB100/100 mice at any time point.
CONC L U S I O N S The 6-month-old LDLR/ApoB100/100 and IGF-II/LDLR/ApoB100/100 mice dem-
onstrated highly inﬂamed, large, and extensive atherosclerotic plaques after 4 months of a high-fat diet,
presenting a suitable model for studying the imaging of atherosclerotic plaque inﬂammation with
18F-FDG. The presence of type 2 diabetes did not confound evaluation of plaque inﬂammation with
18F-FDG. (J Am Coll Cardiol Img 2011;4:1294–301) © 2011 by the American College of Cardiology
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1295n mice deficient in low-density lipoprotein recep-
tor (LDLR) and apolipoprotein B48, being able to
synthesize only apolipoprotein B100 (LDLR/
ApoB100/100), severe hypercholesterolemia with
elevated levels of LDL cholesterol develops. This
leads to extensive atherosclerosis that can be accel-
erated with a high-fat diet. The lipoprotein profile
of LDLR/ApoB100/100 mice is highly atherogenic
See page 1302
and resembles that of human familial hypercholes-
terolemia better than any other mouse model cur-
rently available (1–3). Type 2 diabetes increases the
predisposition to atherosclerosis and related cardio-
vascular diseases. A novel insulin-like growth factor
II (IGF-II)/LDLR/ApoB100/100 mouse model
verexpresses IGF-II in pancreatic  cells and
hows characteristics of type 2 diabetes with no
dditional changes in the plasma lipoprotein frac-
ions (1). In both mouse models, age at the start of
high-fat diet and the duration of the diet may
ave drastic effects on the development and com-
osition of plaques (1), and therefore the optimal
ime point for studying the metabolic activity of
laques remains uncertain.
Positron emission tomography (PET) with 18F-
uorodeoxyglucose (18F-FDG) has been used to
ssess inflammation in atherosclerotic plaques be-
ause of its uptake by macrophages with active
lucose metabolism (4,5). A strong 18F-FDG signal
n culprit carotid artery plaques in patients with
ecent stroke (6) and the correlation of 18F-FDG
uptake with macrophage density indicate that PET
imaging with this tracer has the potential to identify
vulnerable atherosclerotic plaques (7,8). However,
the factors that determine 18F-FDG uptake in
therosclerotic plaques still remain incompletely
nderstood (9). Type 2 diabetes increases the pre-
isposition to atherosclerosis and related cardiovas-
ular diseases. Recent studies have shown that high
18F-FDG uptake is frequently observed in individ-
uals with impaired glucose tolerance and type 2
diabetes (10,11).
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for Science and Medicine of the University of Turku. Dr. Knuuti has c
reported that they have no relationships relevant to the contents of thisManuscript received March 2, 2011; revised manuscript received July 6, 2011We report on the effects of age, duration of a
high-fat diet, and type 2 diabetes on atherosclerotic
plaque composition and metabolic activity assessed
by 18F-FDG uptake in 2 different mouse strains:
LDLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100.
M E T H O D S
Animals and study design. All animal experiments
were reviewed and approved by the Lab-Animal
Care & Use Committee of the State Provincial
Office of Southern Finland. A total of 30 LDLR/
ApoB100/100 mice (strain #003000, The Jackson
Laboratory, Bar Harbor, Maine) and 29 IGF-II/
LDLR/ApoB100/100 mice (A. I. Virtanen Insti-
tute for Molecular Sciences, University of
Eastern Finland, Kuopio, Finland) were
used in the experiments. They were di-
vided into 3 groups based on their age: 4,
6, and 12 months and older. The 4- and
6-month-old mice were fed with a
Western-type diet (0.2% total cholesterol,
TD 88137, Harlan Teklad, Harlan Labo-
ratories, Madison, Wisconsin), starting at
the age of 2 months until imaging. Older
mice (12 months) were fed with the
Western-type diet for 3 to 4 months
before imaging. C57BL/6N mice (n 15,
age 7 to 14 months) fed with regular chow
were used as controls. The characteristics
of the studied animals are shown in Table 1.
The mice (N  74) were fasted with ad
libitum access to water for 4 h before the
18F-FDG injection. Before the tracer in-
jection, blood glucose levels were mea-
sured from the femoral vein with a glu-
cometer (One Touch, UltraEasy, LifeScan,
Inc., Milpitas, California). The 18F-FDG (12  3
MBq) was injected intravenously via a tail vein
catheter in isoflurane-anesthetized mice. A subset
of mice (n  34) (Table 1) were imaged in vivo.
After 90 min, the animals were killed, and the
thoracic aorta was excised and rinsed in saline
solution to remove blood. The aorta was frozen, and
innish Foundation for Cardiovascular Research,
he studies were conducted within the Finnish
Research supported by the Academy of Finland,
mi University, and within the Turku Collegium
ulted for Lantheus, Inc. All other authors have
r to disclose.
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1296sequential longitudinal 20- and 8-m cryosections
ere cut with a cryomicrotome at 15°C and
haw-mounted onto microscope slides for autora-
iography (ARG) studies. Radioactivity in the
lood was measured with a gamma counter (Tri-
thler 3”, Hidex, Turku, Finland) that was cross-
alibrated with a dose calibrator (VDC-202, Veen-
tra Instruments, Joure, the Netherlands), and the
earts were collected and preserved in formalin for
urther studies.
18F-FDG PET/computed tomography. A dedicated
small animal PET/computed tomography (CT)
scanner (Siemens, Knoxville, Tennessee) was used
for in vivo imaging 50 min after injection of 13 
4 MBq 18F-FDG. PET images were acquired for
20 min, followed by CT angiography (20 min). To
obtain vascular contrast, an iodinated intravascular
contrast agent (Fenestra VC, Art Advanced Re-
search Technologies Inc., Montreal, Quebec, Can-
ada) was injected (0.2 ml) via a tail vein catheter
without moving the animal. The mice were anes-
thetized with 1.5% isoflurane for injections and
imaging. CT acquisition consisted of 272 projec-
tions with the exposure time of 1200 ms, x-ray
voltage of 80 kVp, and anode current of 500 A for
a full 360° rotation. The PET and CT images were
reconstructed with a filtered back-projection algo-
rithm. Coregistration of PET and CT images was
done using an automatic weighted mutual informa-
tion algorithm and confirmed visually on the basis
of anatomic landmarks. The intensity of in vivo
18F-FDG uptake was quantified by measuring the
percentage of injected radioactivity per gram of
tissue (%IA/g) and corrected for injected radioac-
tivity. The %IA/g was calculated by using the mean
pixel activity value (kBq/ml) within the region of
interest (ROI) placed on the aortic arch (oval ROI
size, 2.1 mm3) and brachiocephalic artery (cylinder
ROI size, 1.3 mm3) in the coronal PET/CT im-
Table 1 Basic Characteristics of Investigated Animals
LDLR/ApoB100
Age, months 4 6
High-fat diet, months 2 4
No. of animals (F/M) 7 (7/0) 10 (1/9)
Weight, g* 23 2 39 7
PET/CT, no. 3 3
IMR  macrophage, %, no. of animals† 6 9
*Values are mean  SD. †The intima-to-media ratio was measured from M
Mac-3–stained aortic crosssections from the level of aortic ostia.
ApoB100/100  mouse expressing only apolipoprotein B100; CT  compute
intima-to-media ratio; LDLR  low-density lipoprotein receptor; ND  not donages, identified on the basis of the CT angiogramby using Inveon Research Workplace software (Sie-
mens). The axial and sagittal views were used to
ensure that the 18F-FDG uptake was from the
artery.
Autoradiography. The thoracic aortas of all mice
(N  74) were studied with ARG to determine the
uptake of 18F-FDG in atherosclerotic plaques and
in healthy vessel wall, as described previously (11).
Longitudinal 20- and 8-m cryosections of the
orta were cut, air-dried for 5 min, and apposed to
n imaging plate (Fuji Imaging Plate BAS-
R2025, Fuji Photo Film Co., Ltd., Tokyo, Japan).
fter an exposure time of 4 h, the imaging plates
ere scanned with Fuji Analyzer BAS-5000 (inter-
al resolution of 25 m). The 20-m sections were
tained with hematoxylin and eosin, and 8 to 10
ections from each mouse were examined for mor-
hology under a light microscope. After a careful
oregistration of the autoradiographs and hematox-
lin and eosin images, 18F-radioactivity was mea-
ured from the following ROIs: 1) noncalcified
laque (excluding media); 2) calcified area in plaque
excluding media); and 3) normal vessel wall (no
esion formation) (Fig. 1) and expressed as count
ensities (photostimulated luminescence [PSL]/
m2) using Tina 2.1 software (Raytest Iso-
topemessgeräte, GmbH, Straubenhardt, Germany).
The count densities of background radiation were
subtracted from the actual ROI data, and the results
for each mouse were normalized for injected radio-
activity and decay. The analysis method has previ-
ously been reported to be reproducible (coefficient
of variation of 2 independent observers: 4.5%) (12).
The 8-m cryosections were stained with a rat
nti-mouse Mac-3 antibody (Clone M3/84, 1:
000, BD Pharmingen, Franklin Lakes, New Jer-
ey) as described previously (12) to compare the
18F-FDG uptake and density of macrophages in
atherosclerotic plaques. Based on a semiquantitative
Mice IGF-II/LDLR/ApoB100/100 Mice C57BL/6N
12–17 4 6 12–15 7–14
3–4 2 4 3 ND
13 (2/11) 9 (7/2) 9 (6/3) 11 (5/6) 15 (0/15)
41 7 25 6 32 8 38 4 38 4
9 2 3 8 6
3 5 9 8 ND
staining and the percentage of intimal macrophages was quantiﬁed from
mography; F/M  female/male; IGF-II  insulin-like growth factor II; IMR 
T  positron emission tomography./100
ovat
d toanalysis of Mac-3 staining, the plaques were cate-
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1297gorized into: 1) noninflamed (none or occasional
Mac-3 stained macrophages); and 2) inflamed (oc-
casional and some groups of macrophages or abun-
dant infiltration of macrophages).
Histology and immunohistochemistry. To compare
laque areas (intima-to-media ratio [IMR]) and
acrophage infiltration of plaques between groups,
-m serial sections of formalin-fixed and paraffin-
embedded hearts were cut at the level of the aortic
root and stained with anti-mouse Mac-3 or modi-
fied Movat’s pentachrome stain (Table 1). The
sections were evaluated under a light microscope,
high-resolution digital photomicrographs were cap-
tured, and the areas of intima and media were
limited by using image editing software (Adobe
Photoshop cp, Adobe Systems, San Jose, California).
The proportion of macrophages in the intima was
determined from the Mac-3–stained sections, and the
IMRs were calculated from the Movat-stained sec-
tions using automated image analysis software
(Image-Pro Plus 5.0, Media Cybernetics, Silver
Spring, Maryland). Furthermore, the IMR  macro-
phage (%) factor was used to describe the amount of
macrophages compared with plaque size.
Statistical methods. All results are expressed as mean
SD values. Comparisons of nonpaired data between
2 groups were made using a t test and between
multiple groups using analysis of variance with
Tukey’s correction. A paired t test was used for
comparing paired data between 2 groups. All anal-
Figure 1. An Example of Autoradiography Analysis
(A) Hematoxylin-eosin image. (B) Coregistered autoradiograph and
hematoxylin and eosin image) of the same section. R1 and R2  re
normal vessel wall; R5  ROI in calciﬁed plaque area. A  arch; AA
racic aorta; LC  left common carotid artery; LS  left subclavian ayses were performed with SAS software, version 9.1 ((SAS Institute, Inc., Cary, North Carolina). Values
of p  0.05 were considered statistically significant.
R E S U L T S
Characterization of atherosclerotic plaques. No ath-
rosclerosis was detected in the aortas of the control
ice, whereas the atherosclerotic mice showed
xtensive atherosclerotic plaques, as seen in Figures 2A
nd 2B. Plaque size, given as the IMR, was com-
arable between the LDLR/ApoB100/100 and
IGF-II/LDLR/ApoB100/100 mice, and it in-
creased from 4 months to 6 and 12 months in
both strains (Fig. 2C). Macrophage density was
highest at 4 and 6 months of age and decreased by
12 months of age (Fig. 2D). As a result, the
indicator of the total plaque macrophage number
calculated as the IMR  macrophage (%) factor
(Fig. 2E) was highest at 6 months of age in
IGF-II/LDLR/ApoB100/100 mice and at both 6
nd 12 months of age in LDLR/ApoB100/100
mice.
Blood 18F-FDG uptake and glucose values. The 18F-
FDG radioactivity in blood was at the same level in
the LDLR/ApoB100/100 (1.1  0.4 IA%/g,
pooled data, p  0.4, compared with IGF-II/
LDLR/ApoB100/100, p  0.2, compared with
57BL/6N mice), IGF-II/LDLR/ApoB100/100
(1.2  0.5 IA%/g, pooled data, p  0.5 compared
ith C57BL/6N mice), and C57BL/6N control
atoxylin and eosin image (red lines represent the borders of the
s of interest (ROIs) in plaque (noncalciﬁed); R3 and R4  ROIs in
scending aorta, B  brachiocephalic artery; D  descending tho-
y.hem
gion
 a0.9  0.4 IA%/g) mice. No significant differences
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1298were observed in blood glucose values between the
LDLR/ApoB100/100 (7.2  1.5 mmol/l), IGF-
I/LDLR//ApoB100/100 (6.9  1.6 mmol/l) or
57BL/6N control (7.8 1.8 mmol/l) mice after a 4-h
ast.
18F-FDG PET/CT. In vivo imaging demonstrated a
focal 18F-FDG signal in aortic arch and in brachio-
cephalic artery (Fig. 3). Compared with healthy
control mice, the in vivo 18F-FDG uptake in the
ortic arch and brachiocephalic artery was signifi-
antly higher in the LDLR/ApoB100/100 mice at
the age of 6 months (p  0.04 and p  0.01,
espectively), and in the IGF-II/LDLR/
ApoB100/100 mice at the age of 4 months (p 0.005
and p 0.02, respectively) and 6 months (p 0.01
and p  0.01, respectively). There were no signif-
icant differences in 18F-FDG uptake between the
DLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mice in any age group.
Autoradiography. Altogether 4,444 ROIs (2,469
rom plaques and 1,975 from normal vessel walls)
ere analyzed from the 20-m sections of athero-
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Figure 2. Characterization of Atherosclerosis Plaques of LDLR/
Representative aortic root sections stained with Movat or anti-mou
IGF-II/LDLR/ApoB100/100 (B) mice at different ages. (C) Mean ( S
mal area. (E) Factor of IMR  proportion of macrophages (%) from
B100; IGF-II  insulin-like growth factor II; LDLR  low-density lipoclerotic and control mice. Calcified plaques wereeen in all mice 12 months and older (21% of
nalyzed plaques) and in 11 of 19 mice age 6
onths (6% of analyzed plaques), but only in 1
DLR/ApoB100/100 mouse age 4 months (2% of
nalyzed plaques). No differences were found in
SL/mm2 for the ROIs between the noncalcified
laques and calcified areas in plaques (measured
rom the same animal), and therefore these data
ere pooled. As shown in Table 2, the uptake of
18F-FDG was 2 to 2.4 times higher in atheroscle-
rotic plaques than in the normal vessel wall (p 
0.001) in all groups of atherosclerotic mice. The
uptake levels of 18F-FDG in plaques and normal
essel walls were comparable between the LDLR/
ApoB100/100 and IGF-II/LDLR/ApoB100/100
mouse strains and at different ages in both athero-
sclerotic strains. Furthermore, the uptake level of
18F-FDG in the normal vessel wall was comparable
between the atherosclerotic mice and healthy
controls.
The uptake of 18F-FDG was 1.7  0.5 fold
higher in inflamed (25  14 PSL/mm2, n  354)
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1299plaques (p  0.0001 [Fig. 4], pooled data from
6-month-old and 12-month and older LDLR/
ApoB100/100 and IGF-II/LDLR/ApoB100/100
mice), as analyzed from the 8-m anti-mouse
ac-3–stained sections. The 4-month-old mice
ere not included in the analysis because of lack of
oninflamed plaques in these groups.
D I S C U S S I O N
To date, 18F-FDG is the best characterized tracer
available for PET imaging, providing a noninvasive
method for studying inflammation associated with
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Figure 3. 18F-FDG PET/CT Imaging
Representative in vivo PET (A), CT angiography (C), and fused PET/CT
age uptake of 18F-FDG measured in the aortic arch (white arrows in A
ApoB100/100 and IGF-II/LDLR/ApoB100/100 mice expressed as percent
CT  computed tomography; 18F-FDG  18F-ﬂuorodeoxyglucose; PET
Table 2. Autoradiography Results of 18F-FDG Uptake in Aortic C
LDLR/ApoB100/100
Age, months 4 6
Plaque 69 23 61 34
Normal vessel wall 34 8 29 20
Ratio* 2.0 0.3 2.3 0.5
p Value† 0.0006 0.0002
Values are expressed as photostimulated luminescence/mm2 (mean  SD). *Pla
in Table 1.atherosclerotic lesions (9,13). In the present study,
we used 18F-FDG to investigate the metabolic
activity of atherosclerotic plaques in atherosclerotic
LDLR/ApoB100/100 and diabetic as well as ath-
rosclerotic IGF-II/LDLR/ApoB100/100 mice.
here were no major differences in the vascular
18F-FDG uptake and plaque development between
the LDLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mouse strains. The 6-month-old mice
kept on a high-fat diet for 4 months demonstrated
large and macrophage-rich atheromatous plaques.
These mice can be considered particularly useful for
the evaluation of new imaging agents for the detection
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ositron emission tomography; other abbreviations as in Figure 2.
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1300of advanced atherosclerotic plaques. This was con-
firmed by the highest plaque uptake of 18F-FDG
shown both by in vivo PET/CT imaging and by ex
vivo ARG.
Given that type 2 diabetes and impaired glucose
tolerance, on the one hand, are associated with an
increased risk of atherosclerotic cardiovascular
events and, on the other hand, may have an influ-
ence on the uptake and kinetics of glucose analog
18F-FDG (9–11), we aimed to investigate the effect
of the diabetic background on vascular 18F-FDG
uptake in the IGF-II/LDLR/ApoB100/100 mice.
The novel IGF-II/LDLR/ApoB100/100 mouse
epresents a promising model for studies of macro-
ascular complications in type 2 diabetes with
nsulin resistance, hyperglycemia, and mild hyper-
nsulinemia with a hypercholesterolemic back-
round. In IGF-II/LDLR/ApoB100/100 mice,
increased blood glucose values have been reported
in the prolonged fasted state, whereas fed-state
glucose levels were comparable to those of LDLR/
ApoB100/100 mice (1). In the present study, both the
DLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mice were fasted for 4 h and had
qual blood glucose levels and showed similar dis-
ribution of 18F-FDG in blood. Our result that
plaque uptake of 18F-FDG is comparable in the
LDLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mice indicates that the diabetic metab-
lism itself does not affect the feasibility of 18F-
DG for imaging atherosclerotic plaques in these
odels. Furthermore, as to the plaque develop-
ent, no significant differences were found between
he LDLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mice, suggesting that the lesion pro-
Figure 4. Colocalization of 18F-FDG and Density of Macrophage
Macrophages stained with anti-mouse Mac-3 (brown color) in inﬂa
W  wall; other abbreviation as in Figure 3.gression in these models is mainly dependent on tincreased cholesterol level after 2 to 4 months on a
high-fat diet. As reported previously, sex seems to
have no influence on plaque development in the
LDLR/ApoB100/100 and IGF-II/LDLR/
ApoB100/100 mice (1).
Although several mouse models have proved
seful in atherosclerosis research, the occurrence of
laque rupture and thrombosis is extremely rare in
ice. Nevertheless, the histology of atherosclerotic
laque development in mice and humans has more
imilarities than differences, and comparative genet-
cs show that many mechanisms of murine and
uman atherogenesis are shared (14). Mouse
laques are particularly rich in macrophages, which
llow the imaging of plaque inflammation, which is
n important mechanism of plaque progression and
typical feature of plaques at high risk of rupture.
n the present study, the highest 18F-FDG signal in
the aortic arch and brachiocephalic artery was de-
tected in the 6-month-old LDLR/ApoB100/100
and IGF-II/LDLR/ApoB100/100 mice in which
istology and immunohistochemical assessments
emonstrated the highest IMR  macrophage (%)
actor with the largest plaques, given as IMR, and
he highest macrophage density. This is consistent
ith previous studies indicating that the highest
ptake of 18F-FDG is seen in the plaques with the
highest macrophage density (15). After a 2-month
high-fat diet, both the LDLR/ApoB100/100 and
GF-II/LDLR/ApoB100/100 mice demonstrated
n extremely high proportion of infiltrated macro-
hages in plaques already at the age of 4 months. At
his stage, however, the small size of the plaques
imits their use in imaging studies. In mice 12
onths and older and kept on a high-fat diet for 3
Atherosclerotic Plaques
plaque (A), and noninﬂamed (B) plaque. L  lumen; P  plaque;s in
medo 4 months, the plaques were characterized by large
v
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1301areas of calcification and necrotic core, but a rela-
tively low content of macrophages. Although ARG
showed higher 18F-FDG uptake in these plaques
compared with the adjacent healthy vessel wall, the
difference was not significant when atherosclerotic
and healthy mice were compared using in vivo
imaging. Therefore, these older mice are not rec-
ommended for studies that require a high degree of
plaque inflammation. The average life span of a
mouse is about 2 years, but the life expectancy and
causes of death have not been reported for the
mouse models used in the present study (16).
Study limitations. A limitation of our study is that we
were not able to correct in vivo images for partial
volume effects and quantitatively compare in vivo
measurements with ARG or histology in the same
atherosclerotic plaques. In vivo measurements were
done in the arch region because of the most prominent
plaque and a good angiography image in this region.
To minimize the effect of tissue sampling and variable
cutting plane of tissue sections on ARG measure-
ments, results were averaged over multiple plaques in
the thoracic aorta. Standardized sectioning through
the aortic root was used for comparison of histologicalFryer TD, et al. Carotid plaque inflam-
mation is associated with cerebral mi-
1
1
type 2 diabetes. Ci
aging 2010;3;142–8C O N C L U S I O N S
No differences were found between the age-
matched LDLR/ApoB100/100 and IGF-II/
LDLR/ApoB100/100 mice with regard to plaque
development and composition. For the evaluation
of new imaging agents for the detection of advanced
atherosclerotic plaques, we recommend using at
least 6-month-old mice fed a high-fat diet for 3 to
4 months before imaging. The presence of type 2
diabetes did not significantly influence the vascular
uptake of 18F-FDG in the IGF-II/LDLR/
ApoB100/100 model.
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